CMCamilla Schmidt Morgen

Camilla Schmidt Morgen

*This is an algorithmically generated author record based on publicly available information.

Camilla Schmidt Morgen has a total of 592 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Weight change and short-term risk of hypertension in healthy adults

    by Line H S Nielsen, Bertram Kjerulff, Camilla S Morgen, Jutta K H Skau, Martin Hey-Mogensen, Zahra McVey, Susan Mikkelsen, Kathrine A Kaspersen, Ole Frøbert, Lotte A Hindhede, et al.

    Aims: Obesity is a major risk factor for hypertension, but most evidence relies on single weight measurements. We examined associations between weight change and short-term risk of incident hypertension across body mass index (BMI) categories. Methods and results: We conducted a retrospective cohort study in the Danish Blood Donor Study of 81 954 participants aged 18–79 with at least two questionnaires (2010–2025). Weight change was the percentage difference between consecutive self-reported weights, grouped as stable, 2.5–5, 5–10, or more than 10% loss or gain. Incident hypertension was defined as first redemption of antihypertensive drugs. Associations were estimated using multivariable Cox models. During a median follow-up of 1.66 years (IQR 0.79–2.88; maximum 3 years), 5503 participants initiated antihypertensive treatment. In BMI-stratified analyses, weight gain was associated with higher risk of initiation in all BMI categories, while weight loss was associated with lower risk only in overweight or obesity relative to stable weight. Across BMI categories using stable normal weight as reference, associations were stronger at higher BMI. More than 10% weight gain was associated with hazard ratios of 1.60 (95% CI 1.30–1.96) in normal weight, 2.44 (2.02–2.96) in overweight and 4.51 (3.57–5.70) in obesity. Hazard ratios were comparable across sex and age groups, although higher in younger men with obesity, while rates were highest in older participants. Conclusion: Weight gain was associated with higher risk of antihypertensive treatment across BMI categories compared with stable weight, whereas weight loss was inversely associated with initiation among adults with overweight or obesity.

  • Open Access

    Change in body mass index and disease burden among people with obesity and multiple long‐term conditions

    by Kamlesh Khunti, Alex Mourer, Silvia Capucci, Lua Wilkinson, Klaus K. Andersen, Abd A. Tahrani, Camilla S. Morgen

    Aims: Obesity is a risk factor for multiple long‐term conditions (MLTCs/multimorbidity). However, the impact of weight loss in people with MLTCs is unclear. We investigated the association between body mass index (BMI) change and the development of obesity‐related complications (ORCs), as well as clinical and economic outcomes in individuals with obesity and MLTCs. Materials and Methods: This cohort study included adults aged ≤70 years with BMI ≥30 kg/m 2 and ≥2 ORCs. BMI was recorded during Years 1 and 4 of the baseline period. BMI change was categorised as increases or decreases of 3%–7%, 7%–15% and 15%–30%. Data were analysed using Cox regression (hazard ratios [HRs] for mental‐health conditions, hospitalisation and mortality) and Ghosh–Lin models (risk of ≥1 new ORC and clinical consultations). Results: A total of 618 426 individuals were included. The mean number of ORCs at index (Year 4) was 3.8 (standard deviation 1.5). HRs (95% confidence intervals) for incident ORCs were 0.96 (0.94–0.98), 0.98 (0.96–0.99) and 0.98 (0.97–0.99) for the highest to lowest BMI reductions, respectively; BMI increases were associated with HRs >1.00. Risk ratios for consultations were 0.99 (0.98–1.00), 0.99 (0.98–1.00) and 1.00 (0.99–1.00). BMI reductions were linked to lower polypharmacy rates. Both BMI decrease and increase were associated with higher HRs for mental‐health conditions, hospitalisation and mortality versus stable BMI. Conclusions: Weight loss in individuals with obesity and MLTCs was linked to both favourable and adverse outcomes, highlighting the importance of personalised treatment approaches that consider outcomes beyond weight loss.


  • Healthcare utilization associated with obesity management in Ontario, Canada

    by Sean Wharton, Adel Belloum, Maria Luckevich, Elham Kamran, Artis Luguzis, Maria Eberg, Atif Kukaswadia, Calum S. Neish, Silvia Capucci, Anette Varbo, et al.

    Summary: This study aimed to describe the characteristics, healthcare resources utilized and costs incurred by adults receiving publicly funded obesity care in Ontario, Canada. People living with obesity who first visited Wharton Medical Clinic, a weight and diabetes management clinic in Ontario, between 2015 and 2018 were identified. Pseudoanonymized data were linked to administrative databases to understand healthcare utilization and costs borne by the public payer over 3 years. 6208 participants had linked data, 63.9% and 27.3% of whom remained followed one and two years after their first clinic visit, respectively. The cohort was 71.84% female with a mean (SD) age of 50.86 (13.28) years and BMI of 40.21 (7.06) kg/m2. Approximately 25% of participants were prescribed pharmacotherapy (liraglutide, orlistat, naltrexone/bupropion), 4% received psychological therapy and 2% had weight‐loss surgery. Common obesity‐related complications were hypertension (42.62%), musculoskeletal pain (35.20%) and dyslipidaemia (33.65%). Participants had 22.16 physician visits per person‐year in year one, mostly to general practitioners and endocrinologists, which decreased to 17.38 visits per person‐year by year three. Mean total costs (excluding privately covered prescriptions) per person‐year decreased from $5227.25 (Canadian dollars) (SE: $0.97) to $4982.88 (SE: $2.16) over the same period. Participants were mostly female and presented with obesity‐related complications. Although healthcare utilization and costs incurred by the cohort were high, both showed a decreasing trend over the follow‐up period.


  • Open Access

    Cover Image

    by Kamlesh Khunti F. MedSci, Volker Schnecke, Christiane Lundegaard Haase, Nina M. Harder‐Lauridsen, Naveen Rathor, Kasper Sommer, Camilla S. Morgen

  • Open Access

    Weight change and risk of obesity‐related complications: A retrospective population‐based cohort study of a UK primary care database

    by Kamlesh Khunti F. MedSci, Volker Schnecke, Christiane Lundegaard Haase, Nina M. Harder‐Lauridsen, Naveen Rathor, Kasper Sommer, Camilla S. Morgen

    Aims: To examine associations between weight loss/gain and risk of developing 13 obesity‐related complications (ORCs), stratified by baseline body mass index (BMI). Materials and Methods: In this retrospective cohort study, we included adults with obesity (>30 kg/m 2 ) from the UK Clinical Practice Research Datalink GOLD database with weight change (−50% to +50%) between Years 1 and 4 (N = 418 774 [median follow‐up: 7 years]). Associations between weight change, baseline BMI and risk of developing ORCs during follow‐up were assessed using Cox proportional hazard models. Results: The impact of weight change on ORCs was generally dependent on baseline BMI. Four clear patterns were seen across the 13 outcomes. Pattern 1 showed greatest weight loss benefit for people with low baseline BMI (type 2 diabetes, sleep apnoea, hypertension and dyslipidaemia); Pattern 2 showed most weight loss benefit at lower baseline BMI but no significant weight loss effect at higher baseline BMI (asthma, hip/knee osteoarthritis and polycystic ovary syndrome); Pattern 3 showed benefit in most cardiovascular diseases with weight loss (chronic kidney disease, heart failure, atrial fibrillation and venous thromboembolism), but no additional benefit with >10% weight loss; Pattern 4 showed no clear relationship between weight change and unstable angina/myocardial infarction and depression. We found similar but opposite patterns for weight gain. Conclusions: Weight loss benefit is dependent on weight loss magnitude and initial BMI, and weight gain is associated with a similar risk increase. Four patterns of association were identified between degree of weight change, baseline BMI and 13 ORCs.


  • Open Access

    Disease Burden and Health Status among People with Severe Obesity Who Do Not Receive Bariatric Surgery: A Retrospective Study

    by Jamy Ard, Cecilie Olivia Andersen, Kasper Sommer Matthiessen, Camilla S. Morgen, Naveen Rathor, Deepak Yerragolam, Tahrani Abd A

    Introduction: The aim of the study was to compare eligible individuals who were or were not treated with bariatric surgery and describe disease burden, treatment, and healthcare costs over 3 years in individuals who were not. Methods: Adults with obesity class II and comorbidities, or obesity class III, were identified in IQVIA Ambulatory EMR – US and PharMetrics® Plus administrative claims databases (January 1, 2007–December 31, 2017). Outcomes included demographics, BMI, comorbidities, and per patient per year (PPPY) healthcare costs. Results: Of 127,536 eligible individuals, 3,962 (3.1%) underwent surgery. The surgery group was younger, a greater proportion were women, and mean BMI and rates of some comorbidities (obstructive sleep apnea, gastroesophageal reflux disease, and depression) were higher than in the nonsurgery group. Mean healthcare costs PPPY in the baseline year were USD 13,981 in the surgery group and USD 12,024 in the nonsurgery group. In the nonsurgery group, incident comorbidities increased during follow-up. Mean total costs increased by 20.5% from baseline to year 3, mostly driven by an increase in pharmacy costs; however, fewer than 2% of these individuals initiated antiobesity medications. Conclusions: Individuals who did not undergo bariatric surgery showed a progressive worsening of health and increasing healthcare costs, indicating a large unmet need for access to clinically indicated obesity treatment.


  • Open Access

    Smoking during pregnancy is associated with child overweight independent of maternal pre-pregnancy BMI and genetic predisposition to adiposity

    by Theresia M. Schnurr, Lars Ängquist, Ellen Aagaard Nøhr, Torben Hansen, Thorkild I. A. Sørensen, Camilla S. Morgen

    High maternal body mass index (BMI) and smoking during pregnancy are risk factors for child overweight. Maternal smoking tends to reduce her BMI and the association of smoking with child overweight may be confounded by or interacting with maternal genetic predisposition to adiposity. In the Danish National Birth Cohort, we investigated whether smoking during pregnancy is associated with child BMI/overweight independent of pre-pregnancy BMI and maternal genetic predisposition to adiposity estimated as total, transmitted and non-transmitted genetic risk scores (GRSs) based on 941 common genetic variants associated with BMI. Smoking during pregnancy was associated with higher child BMI and higher odds of child overweight in a dose–response relationship. The odds ratio (95% CI) for smoking 11 + cigarettes in third trimester versus no smoking was 2.42 (1.30; 4.50), irrespective of maternal BMI and maternal GRSs (total, transmitted or non-transmitted). There were no statistically significant interactions between maternal GRSs and smoking (all p-values for interactions > 0.05). In conclusion, in this study, smoking during pregnancy exhibits a dose–response association with increased child BMI/overweight, independent of maternal pre-pregnancy BMI, maternal transmitted, and non-transmitted genetic predisposition to adiposity. Avoidance of smoking during pregnancy may help prevent childhood obesity irrespective of the mother–child genetic predisposition.


  • Open Access

    Antibiotic treatment during early childhood and risk of type 1 diabetes in children: A national birth cohort study

    by Julie Christine Antvorskov, Camilla Schmidt Morgen, Karsten Buschard, Tine Jess, Kristine Højgaard Allin, Knud Josefsen

    Aim Antibiotics are widely used during childhood infections and influence the composition of the microbiota, which is established during the first years of life. Evidence from animal models of type 1 diabetes shows that antibiotics might accelerate disease progression, and altered intestinal microbiota has been reported in association with type 1 diabetes in humans. We aimed to test the hypothesis that early exposure to antibiotics (0‐24 months of age) was associated with an increased risk of childhood type 1 diabetes development. Methods We studied 75 615 mother‐child dyads from the Danish National Birth Cohort. Information on the use of antibiotics during early childhood and type 1 diabetes development in childhood was available for all children via linkage to the Danish National Prescription Registry and the Danish National Patient Register, respectively. The mean follow‐up time was 14.3 years (range 11.5 to 18.4 years, SD 1.4). Results After adjustment for confounders, we found no association between antibiotic exposure and risk of type 1 diabetes (HR 1.26, 95% CI 0.89‐1.79). The number of antibiotic courses during early childhood was not associated with type 1 diabetes development when analyzing for one (HR 1.31, 95% CI 0.87‐1.99), two (HR 0.99, 95% CI 0.61‐1.63), or 3 or more (HR 1.42, 95% CI 0.95‐2.11) courses. Furthermore, no specific types of antibiotics (penicillins/beta‐lactam antibacterials, sulfonamide/trimethroprim or macrolides/lincosamides/streptogramins) were associated with increased risk of type 1 diabetes. Conclusion Our nationwide cohort study suggests that postnatal exposure to antibiotics does not influence the development of childhood type 1 diabetes.


  • Open Access

    Overweight in childhood of exclusively breastfed infants with a high weight at 5 months

    by Camilla S. Morgen, Melanie W. Larsson, Lars Ängquist, Thorkild I. A. Sørensen, Kim F. Michaelsen

    High infant weight increases the risk of childhood overweight, while breastfeeding may reduce the risk. However, some infants have a very high weight gain even though they are exclusively breastfed. We examined the risk of a high body mass index (BMI) and overweight in childhood for infants ≥2.5 SD above the median weight‐for‐age (WAZ) at age 5 months according to duration of exclusive breastfeeding (≤2, >2 to 2 to z‐scores were 0.82 (95% CI [0.60, 1.04]), 0.63 (95% CI [0.48, 0.78]) and 0.57 (95% CI [0.38, 0.77]). For the ≥2.5 SD infants, the differences in risk of overweight and BMI according to duration of exclusive breastfeeding were neither significantly different among the 7‐year nor among the 11‐year‐old children. A high infant weight increases the odds of overweight and is associated with a higher BMI in childhood. Whereas the odds and BMIz‐scores tended to be lower for those exclusively breastfed longer, the differences were not statistically significant.


  • Open Access

    Changes in parental smoking during pregnancy and risks of adverse birth outcomes and childhood overweight in Europe and North America: An individual participant data meta-analysis of 229,000 singleton births

    by Elise M. Philips, Susana Santos, Leonardo Trasande, Juan J. Aurrekoetxea, Henrique Barros, Andrea von Berg, Anna Bergström, Philippa K. Bird, Sonia Brescianini, Carol Ní Chaoimh, et al.

    Fetal smoke exposure is a common and key avoidable risk factor for birth complications and seems to influence later risk of overweight. It is unclear whether this increased risk is also present if mothers smoke during the first trimester only or reduce the number of cigarettes during pregnancy, or when only fathers smoke. We aimed to assess the associations of parental smoking during pregnancy, specifically of quitting or reducing smoking and maternal and paternal smoking combined, with preterm birth, small size for gestational age, and childhood overweight. We performed an individual participant data meta-analysis among 229,158 families from 28 pregnancy/birth cohorts from Europe and North America. All 28 cohorts had information on maternal smoking, and 16 also had information on paternal smoking. In total, 22 cohorts were population-based, with birth years ranging from 1991 to 2015. The mothers’ median age was 30.0 years, and most mothers were medium or highly educated. We used multilevel binary logistic regression models adjusted for maternal and paternal sociodemographic and lifestyle-related characteristics. Compared with nonsmoking mothers, maternal first trimester smoking only was not associated with adverse birth outcomes but was associated with a higher risk of childhood overweight (odds ratio [OR] 1.17 [95% CI 1.02–1.35], P value = 0.030). Children from mothers who continued smoking during pregnancy had higher risks of preterm birth (OR 1.08 [95% CI 1.02–1.15], P value = 0.012), small size for gestational age (OR 2.15 [95% CI 2.07–2.23], P value < 0.001), and childhood overweight (OR 1.42 [95% CI 1.35–1.48], P value < 0.001). Mothers who reduced the number of cigarettes between the first and third trimester, without quitting, still had a higher risk of small size for gestational age. However, the corresponding risk estimates were smaller than for women who continued the same amount of cigarettes throughout pregnancy (OR 1.89 [95% CI 1.52–2.34] instead of OR 2.20 [95% CI 2.02–2.42] when reducing from 5–9 to ≤4 cigarettes/day; OR 2.79 [95% CI 2.39–3.25] and OR 1.93 [95% CI 1.46–2.57] instead of OR 2.95 [95% CI 2.75–3.15] when reducing from ≥10 to 5–9 and ≤4 cigarettes/day, respectively [P values < 0.001]). Reducing the number of cigarettes during pregnancy did not affect the risks of preterm birth and childhood overweight. Among nonsmoking mothers, paternal smoking was associated with childhood overweight (OR 1.21 [95% CI 1.16–1.27], P value < 0.001) but not with adverse birth outcomes. Limitations of this study include the self-report of parental smoking information and the possibility of residual confounding. As this study only included participants from Europe and North America, results need to be carefully interpreted regarding other populations. We observed that as compared to nonsmoking during pregnancy, quitting smoking in the first trimester is associated with the same risk of preterm birth and small size for gestational age, but with a higher risk of childhood overweight. Reducing the number of cigarettes, without quitting, has limited beneficial effects. Paternal smoking seems to be associated, independently of maternal smoking, with the risk of childhood overweight. Population strategies should focus on parental smoking prevention before or at the start, rather than during, pregnancy.